Home/BrePco Biopharma/Seamus O'Loan

SO

Seamus O'Loan

Director

BrePco Biopharma

Therapeutic Areas

Pediatric Critical Care Cardiovascular

BrePco Biopharma Pipeline

Drug	Indication	Phase
Neoatricon® (dopamine hydrochloride)	Hypotension in haemodynamically unstable neonates, infants, and children under 18	Approved

Leadership Team at BrePco Biopharma

Founder and Director

Manager of Quality and Compliance

View full BrePco Biopharma profile